BECN1 and Parkinson disease: Furthermore, syringin shows promise as a candidate agent for preventing and treating Parkinson’s disease by inducing autophagy through partially regulating the microRNA-34 Alpha/Sirtuin 1/Beclin-1 (miR-34α/SIRT1/BECN1) axis to prevent 6-oxidopamine hydrobromide (6-OHDA)-induced apoptosis and α-synuclein accumulation (Fu et al., 2023).